Suppr超能文献

利用CFU-C和HTSCA检测法对6-[双-(2-氯乙基)-氨基]-6-脱氧-D-葡萄糖与美法仑的骨髓毒性和抗肿瘤活性进行的体外比较研究。

In vitro comparative studies of the myelotoxicity and antitumor activity of 6-[bis-(2-chloroethyl)-amino]-6-deoxy-D-glucose versus melphalan utilizing the CFU-C and HTSCA assays.

作者信息

Lazarus P, Dufour M, Isabel G, Panasci L C

出版信息

Cancer Chemother Pharmacol. 1986;16(2):148-52. doi: 10.1007/BF00256165.

Abstract

6-[Bis-(2-chloroethyl)-amino]-6-deoxy-D-glucose (C-6) is a new glucose-containing nitrogen mustard that has significant activity for murine P388 leukemia with relative sparing of bone marrow in mice. The in vitro myelotoxicity of C-6 compared with that of melphalan, a clinically active, myelosuppressive nitrogen mustard, was determined in the CFU-C assay in human bone marrow samples obtained from normal volunteers. There was no significant difference between the myelosuppressive actions of C-6 and melphalan at any of the concentrations used except for 4.0 microM, at which C-6 was significantly (P less than 0.05) more toxic than melphalan. Both agents decreased the number of bone marrow cell colonies to approximately 12% of control at 6.6 microM (1 h incubation), which is a good approximation of melphalan's CxT (concentration by time) in man. We used the human tumor stem cell assay (HTSCA) to investigate in vitro antitumor activity. We obtained two specimens of malignant melanoma and two of malignant ovarian carcinoma from patients not previously treated with chemotherapy. The antitumor activity of melphalan was either similar to or greater than that of C-6 at all concentrations utilized against any of the four tumor specimens, except at 1.3 microM for tumor I. In particular, there was no significant difference in the antitumor activities of the two agents at 6.6 microM. These results suggest that C-6 will not be less myelosuppressive than melphalan at doses that produce equivalent antitumor activity in man. In addition, C-6 did not demonstrate increased myelotoxicity for normal human bone marrow cells incubated in glucose-deficient medium as against medium containing 300 mg% glucose at any of the concentrations used. This suggests that C-6 is not transported into normal human bone marrow cells via the glucose transport system, despite the presence of a glucose moiety within the molecule.

摘要

6-[双-(2-氯乙基)-氨基]-6-脱氧-D-葡萄糖(C-6)是一种新型含葡萄糖的氮芥,对小鼠P388白血病具有显著活性,且对小鼠骨髓有相对保护作用。在从正常志愿者获取的人骨髓样本的集落形成单位 - 细胞(CFU - C)测定中,测定了C-6与人苯丙氨酸氮芥(一种临床活性的骨髓抑制性氮芥)相比的体外骨髓毒性。除了4.0微摩尔浓度外,在所用的任何浓度下,C-6和苯丙氨酸氮芥的骨髓抑制作用均无显著差异,在该浓度下C-6的毒性显著(P小于0.05)高于苯丙氨酸氮芥。在6.6微摩尔浓度(孵育1小时)时,两种药物均将骨髓细胞集落数量减少至对照的约12%,这很好地近似了苯丙氨酸氮芥在人体中的CxT(浓度乘以时间)。我们使用人肿瘤干细胞测定法(HTSCA)来研究体外抗肿瘤活性。我们从先前未接受过化疗的患者中获得了两份恶性黑色素瘤标本和两份恶性卵巢癌标本。在针对四个肿瘤标本中的任何一个所使用的所有浓度下,苯丙氨酸氮芥的抗肿瘤活性与C-6相似或高于C-6,但肿瘤I在1.3微摩尔浓度时除外。特别是,在6.6微摩尔浓度时,两种药物的抗肿瘤活性没有显著差异。这些结果表明,在人体中产生等效抗肿瘤活性的剂量下,C-6的骨髓抑制作用不会低于苯丙氨酸氮芥。此外,在所用的任何浓度下,与含300mg%葡萄糖的培养基相比,C-6对在葡萄糖缺乏培养基中孵育的正常人骨髓细胞未表现出增加的骨髓毒性。这表明,尽管分子中存在葡萄糖部分,但C-6并非通过葡萄糖转运系统转运至正常人骨髓细胞中。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验